Travelan
- Generic Name
- Travelan
Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model
Phase 2
Active, not recruiting
- Conditions
- DiarrheaInfectious DiarrheaTravelers Diarrhea
- Interventions
- Other: Placebo
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Immuron Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05933525
- Locations
- 🇺🇸
Pharmaron Clinical Pharmacology Center, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath